IL98810A - Pharmaceuticals containing flopirtin against disorders of muscle tension and their preparation - Google Patents

Pharmaceuticals containing flopirtin against disorders of muscle tension and their preparation

Info

Publication number
IL98810A
IL98810A IL9881091A IL9881091A IL98810A IL 98810 A IL98810 A IL 98810A IL 9881091 A IL9881091 A IL 9881091A IL 9881091 A IL9881091 A IL 9881091A IL 98810 A IL98810 A IL 98810A
Authority
IL
Israel
Prior art keywords
optionally
flupirtine
disorders
preparation
muscular
Prior art date
Application number
IL9881091A
Other languages
English (en)
Hebrew (he)
Other versions
IL98810A0 (en
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of IL98810A0 publication Critical patent/IL98810A0/xx
Publication of IL98810A publication Critical patent/IL98810A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paints Or Removers (AREA)
  • Golf Clubs (AREA)
  • Details Of Television Scanning (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
IL9881091A 1990-07-14 1991-07-12 Pharmaceuticals containing flopirtin against disorders of muscle tension and their preparation IL98810A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4022442 1990-07-14
IN421CA1991 IN172468B (fr) 1990-07-14 1991-06-04

Publications (2)

Publication Number Publication Date
IL98810A0 IL98810A0 (en) 1992-07-15
IL98810A true IL98810A (en) 1996-01-19

Family

ID=25895002

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9881091A IL98810A (en) 1990-07-14 1991-07-12 Pharmaceuticals containing flopirtin against disorders of muscle tension and their preparation

Country Status (30)

Country Link
US (2) US5162346A (fr)
EP (2) EP0659410B1 (fr)
KR (1) KR0182811B1 (fr)
CN (1) CN1070700C (fr)
AT (2) ATE133564T1 (fr)
AU (1) AU634073B2 (fr)
CA (1) CA2046943C (fr)
CZ (1) CZ280879B6 (fr)
DE (3) DE59109222D1 (fr)
DK (2) DK0467164T3 (fr)
EG (1) EG19814A (fr)
ES (2) ES2164111T3 (fr)
GR (1) GR3019179T3 (fr)
HR (1) HRP920667B1 (fr)
HU (1) HU206973B (fr)
IE (1) IE74688B1 (fr)
IL (1) IL98810A (fr)
IN (1) IN172468B (fr)
LT (1) LT3593B (fr)
LV (1) LV10048B (fr)
MC (1) MC2272A1 (fr)
MX (1) MX9100160A (fr)
NO (1) NO912758L (fr)
NZ (1) NZ238940A (fr)
PT (1) PT98291B (fr)
RO (1) RO108220B1 (fr)
RU (1) RU2070408C1 (fr)
SI (1) SI9111227B (fr)
SK (1) SK279567B6 (fr)
ZA (1) ZA915466B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE160696T1 (de) * 1992-03-11 1997-12-15 Asta Medica Ag Tabletten, granulate und pellets mit hohem gehalt an wirkstoffen für hochkonzentrierte, feste darreichungsformen
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
DE19541405A1 (de) * 1995-11-07 1997-05-15 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
US6284794B1 (en) 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
US6610324B2 (en) * 1999-04-07 2003-08-26 The Mclean Hospital Corporation Flupirtine in the treatment of fibromyalgia and related conditions
JP2003530308A (ja) * 1999-08-03 2003-10-14 アーヴェーデー．ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト 犬および猫の退行性関節疾患に起因する痛みを軽減するためのフルピルチンの使用
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
RU2213565C1 (ru) * 2002-06-24 2003-10-10 Общество с ограниченной ответственностью "Паркинфарм" Способ лечебного воздействия на организм пациента при лечении болезни паркинсона
DE10255415A1 (de) * 2002-11-28 2004-06-09 Bayer Healthcare Ag Dermale Applikation von Flupirtin
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
US20050196461A1 (en) * 2004-01-14 2005-09-08 Udell Ronald G. Ceramide formulations suitable for oral administration
CA2554959A1 (fr) * 2004-01-29 2005-08-11 Neuromolecular, Inc. Combinaison d'antagoniste de recepteur nmda et d'inhibiteur mao ou gadpf pour le traitement d'affections liees au systeme nerveux central
US20050220862A1 (en) 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
EP1688141A1 (fr) * 2005-01-31 2006-08-09 elbion AG Utilisation de flupirtine pour le traitement de la vessie hyperactive et des maladies associées et pour le traitement du syndrome du colon irritable
WO2006121560A2 (fr) 2005-04-06 2006-11-16 Adamas Pharmaceuticals, Inc. Procedes et compositions pour le traitement des pathologies associees au systeme nerveux central
US20090318507A2 (en) * 2006-05-02 2009-12-24 Chris Rundfeldt Potassium Channel Activators for the Prevention and Treatment of Dystonia and Dystonia Like Symptoms
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
AU2007288253B2 (en) * 2006-08-23 2013-05-02 Xenon Pharmaceuticals Inc. Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
KR20090083479A (ko) * 2006-11-28 2009-08-03 밸리언트 파마슈티컬즈 인터내셔널 칼륨 채널 조절제로서의 1,4 디아미노 이환 레티가빈 유사체
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US20100256145A1 (en) * 2007-08-01 2010-10-07 H. Lundbeck A/S Use of kcnq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
US8563566B2 (en) * 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
ES2347119B2 (es) * 2009-04-22 2011-04-28 Universidad De Santiago De Compostela Nanocapsulas de poliarginina.
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
JP6251667B2 (ja) * 2014-06-03 2017-12-20 アサヒカルピスウェルネス株式会社 錠剤型即放性製剤及びその製造方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795858C2 (de) 1968-07-19 1979-01-11 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Benzylaminopyridine
DE3133519A1 (de) 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
EP0189788B1 (fr) * 1985-01-23 1989-09-13 ASTA Pharma Aktiengesellschaft Combinaison synergétique de flupirtine et d'anti-phlogistiques non-stéroidaux
DE3604575A1 (de) * 1985-02-23 1986-08-28 Degussa Ag, 6000 Frankfurt Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
DE3663775D1 (en) * 1985-02-23 1989-07-13 Asta Pharma Ag Combination of flupirtin with spasmolytics having an anticholinergic effect
FI855016A (fi) * 1985-06-28 1986-12-29 Degussa Synergistisk kombination av flupirtin och 4-acetamido-fenol.

Also Published As

Publication number Publication date
PT98291A (pt) 1992-05-29
ATE206919T1 (de) 2001-11-15
EP0659410A3 (fr) 1995-10-25
PT98291B (pt) 1999-01-29
LV10048B (en) 1995-06-20
KR920002147A (ko) 1992-02-28
EP0659410B1 (fr) 2001-10-17
HRP920667B1 (en) 1998-06-30
AU634073B2 (en) 1993-02-11
NO912758D0 (no) 1991-07-12
LV10048A (lv) 1994-05-10
IN172468B (fr) 1993-08-14
ES2082887T3 (es) 1996-04-01
KR0182811B1 (ko) 1999-05-01
EP0467164A3 (en) 1992-04-15
DE59109222D1 (de) 2001-11-22
HUT59313A (en) 1992-05-28
EP0467164A2 (fr) 1992-01-22
LT3593B (en) 1995-12-27
MC2272A1 (fr) 1993-06-23
NZ238940A (en) 1997-05-26
NO912758L (no) 1992-01-15
HU912359D0 (en) 1991-12-30
ATE133564T1 (de) 1996-02-15
SK279567B6 (sk) 1999-01-11
DE59107331D1 (de) 1996-03-14
CZ280879B6 (cs) 1996-04-17
HRP920667A2 (en) 1996-10-31
IE912451A1 (en) 1992-01-15
CN1070700C (zh) 2001-09-12
CA2046943A1 (fr) 1992-01-15
DE4122166A1 (de) 1992-01-16
CS210191A3 (en) 1992-02-19
RO108220B1 (ro) 1994-03-31
SI9111227A (en) 1995-06-30
LTIP919A (en) 1995-03-27
EG19814A (en) 1996-02-29
CN1058716A (zh) 1992-02-19
GR3019179T3 (en) 1996-06-30
SI9111227B (sl) 2000-12-31
MX9100160A (es) 1992-02-28
EP0659410A2 (fr) 1995-06-28
IL98810A0 (en) 1992-07-15
IE74688B1 (en) 1997-07-30
ZA915466B (en) 1992-04-29
AU8040391A (en) 1992-01-16
DK0467164T3 (da) 1996-03-04
US5284861A (en) 1994-02-08
EP0467164B1 (fr) 1996-01-31
CA2046943C (fr) 1996-03-12
ES2164111T3 (es) 2002-02-16
DK0659410T3 (da) 2001-12-27
HU206973B (en) 1993-03-01
US5162346A (en) 1992-11-10
RU2070408C1 (ru) 1996-12-20

Similar Documents

Publication Publication Date Title
CA2046943C (fr) Procede de production d'un agent ayant comme substance active de la flupirtine et visant a soulager la tension musculaire
AU622276B2 (en) Medicament containing dihydrolipoic acid as active substance
US4812481A (en) Synergistic combination of amantadiene and selegiline
CA2007480C (fr) Utilisation d'une substance active, l'azelastine pour le traitement du psoriasis et des inflammations
AU601237B2 (en) The use of paroxetine to treat pain
US5068233A (en) Synergistic combination of azelastine and theophylline or azelastine and α-mimetics
JPH07504915A (ja) ムスカリン拮抗物質投与による，哺乳動物の眼における眼内圧低下法
US4839384A (en) Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist
JPH06511231A (ja) ２−（ピロリジニル−１−メチル）−ピペリジン誘導体およびκ受容体アゴニストとしてのその使用
US5290769A (en) Use of hexadecylphosphocholine for the treatment of psoriasis
JPH0525167A (ja) 緑内障の治療に有用な置換ベンゼン誘導体
US6046200A (en) Compositions having neuroprotective and analgesic activity
ITRM940322A1 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione ed applicazione".
JPH01199914A (ja) 妊娠毒血症の予防または治療用組成物
PT95422B (pt) Processo para a preparacao de composicoes farmaceuticas para o tratamento de psoriase incorporando compostos de acidos alquilfosforicos
JP3141051B2 (ja) 抗動脈硬化剤
JPH0532627A (ja) 筋肉痙攣により帰因するか又は筋肉痙攣の結果である疾病及び症候群を治療するための医薬品及びその製法
JPS6026770B2 (ja) 消化管潰瘍治療剤
NZ232059A (en) Compositions and use of an alkyl glycerine and azelastine: (4-(p-chlorobenzyl)-2-(hexahydro-1-methyl-1h-azepine-4-yl)-1(2h)-phthalazinone; preparatory processes
IE84029B1 (en) Use of the compound flupirtin for the preparation of a medicament against muscle bracing
JPH02200632A (ja) 医薬組成物

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired